VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 102 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,346,000 | -29.0% | 16,302,596 | 0.0% | 0.74% | +26.2% |
| Q1 2022 | $20,215,000 | -36.4% | 16,302,596 | 0.0% | 0.58% | -9.0% |
| Q4 2021 | $31,790,000 | -28.8% | 16,302,596 | 0.0% | 0.64% | +20.9% |
| Q3 2021 | $44,669,000 | -13.0% | 16,302,596 | 0.0% | 0.53% | -20.6% |
| Q2 2021 | $51,353,000 | +47.9% | 16,302,596 | 0.0% | 0.67% | -14.1% |
| Q1 2021 | $34,725,000 | +91.2% | 16,302,596 | +74.2% | 0.78% | +62.6% |
| Q4 2020 | $18,158,000 | – | 9,360,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $32,135,000 | 11.34% |
| VR Adviser, LLC | 16,047,286 | $43,970,000 | 5.65% |
| COMMODORE CAPITAL LP | 5,123,509 | $14,038,000 | 3.70% |
| Ghost Tree Capital, LLC | 2,000,000 | $5,480,000 | 1.60% |
| EPIQ PARTNERS, LLC | 916,100 | $2,510,000 | 1.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 707,733 | $1,939,000 | 1.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,824,938 | $10,480,000 | 0.88% |
| HighVista Strategies LLC | 438,239 | $1,201,000 | 0.80% |
| Nicholas Investment Partners, LP | 2,786,354 | $7,635,000 | 0.56% |
| NEA Management Company, LLC | 16,302,596 | $44,669,000 | 0.53% |